INS and autoimmune polyendocrinopathy: Second, it is widely known that type 1 diabetes is characterized by the autoimmune destruction of pancreatic β cells, and the association between APS treatment on pancreatic β cells and T cells, which might mediate diabetes and destroy insulin-producing β cells in the pancreatic islets, was not investigated.